Previous close | 4.5400 |
Open | 4.5400 |
Bid | 0.0000 |
Ask | 4.8000 |
Strike | 460.00 |
Expiry date | 2024-07-19 |
Day's range | 4.5400 - 4.5400 |
Contract range | N/A |
Volume | |
Open interest | 2 |
As the third quarter of 2024 begins, U.S. stocks are showing signs of resilience with notable gains, despite underlying concerns about sector imbalances and interest rate uncertainties. In this context, growth companies with high insider ownership can be particularly compelling, as significant insider stakes often signal confidence in the company's future prospects from those who know it best.
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CINCINNATI, June 26, 2024--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024. The Company will host a conference call the following morning, Tuesday, July 23, 2024, at 9:00 a.m. ET to discuss these results.